Tainted stock broker Ketan Parekh and 8 of his associates received a blow, when the Supreme Court dismissed their appeals against a Sebi order banning them from trading for 14 years.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
While the two high-profile exits in pharmaceutical and telecom have raised concerns over regulatory hassles in the country, Japanese investors are still keen to tap into India's consumer growth story and many more merger and acquisition deals are in the offing in this space.
Indian exporters of ayurvedic drugs are finding it extremely difficult to tap this high-growth segment
Even smaller companies like Torrent Pharma and Alembic file five to 10 ANDAs every year.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
The combined networth of India's 100 wealthiest is $381 billion (nearly Rs 25.5 lakh crore), a rise of 10 per cent from $ 345 billion in 2015
Engineering major BHEL rebounded from its day's lows to end around 1% higher.
Nifty crosses 9,750-mark; Bharti Airtel, TCS, Wipro, Lupin and Coal India gained the most on BSE Sensex
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Better-than-expected financial results in Q3 due to higher revenue growth and margins in key markets fuel the rally
Auto stocks will be in focus
Results of some blue-chip companies exceeded expectations, providing additional thrust, traders said.
Urjit Patel as the new RBI governor whose focus is on taming inflation has lowered the probability of interest rate cut soon
Sun Pharmaceutical, which is growing its dermatology and ophthalmic specialty business in the US will spend $460 million on R&D.
The government is expected to dole out some populist policies, especially for the rural / farm sector while presenting the interim budget, given that the country is heading towards general elections over the next few months.
Among the index heavyweights, Reliance Industries ended down 1.9% while mortage lender HDFC eased 0.2%. FMCG major ITC ended down 1.3%.
FIIs are looking at the long-term story and initiatives of Indian pharma companies to transform themselves into global entities.
The S&P BSE Sensex ended 80 points up at 23,789 while the Nifty50 closed at 7,235, up 24 points.
Sensex climbs higher on favourable global cues.
Take the Rediff Biz Quiz and find out how much you know about brands in India.
In an hour-long chat on rediff.com on Thursday, A K Prabhakar, senior VP and Head -- Equity Research (Retail), Anand Rathi Financial Services Ltd, discussed the best stocks to put the investors' money in.
Firms generated free cash flows in 2013-14, for the first time since the 2008 Lehman crisis
Big bull's holdings cross Rs 7,200 crore (Rs 72 billion).
In an hour-long chat on rediff.com on Friday, A K Prabhakar, senior VP and Head -- Equity Research (Retail), Anand Rathi Financial Services Ltd, discussed the best stocks to put the investors' money in.
The FMCG index gained more than 1% on the back of stellar gains in ITC.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
The calculation excludes cross-holding of listed group cos in each other.
She pocketed Rs 9.12 crore as remuneration in FY16
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
For the second straight week, the Sensex rose, notching up a significant gain of 528.34 points, or 1.59 per cent. The Nifty was up 129.45 points, or 1.25 per cent, during the week.
Sentiments turned somewhat weak towards the middle of the session as profit-booking emerged as investors turned cautious on disappointing quarterly earnings by some bluechip companies
Markets snapped their 8-day winning streak.
The S&P BSE Sensex gained 115 points to end at 24,338 and the Nifty50 climbed 42 points to close at 7,404.
Ajit Mishra, Vice President, Research, Religare Broking, answers readers' stock market queries. Ajit will offer his unbiased views on a weekly basis
The 50-share NSE Nifty ended flat, up 5.80 points, or 0.06 per cent, at 10,308.95.
The 50-issue NSE Nifty in range-bound movements settled higher by 59.15 points, or 0.58 per cent, at 10,252.10.
Aurobindo Pharma, Cadila Healthcare and Serum Institute are readying their vaccine candidates.
Gains were led by index heavyweights with Reliance Industries contributing the most.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances